Cytochrome P-450 CYP2C9 Inhibitors (strong)
- Cytochrome P-450 CYP2C9 Inhibitors (strong)
- Accession Number
Drug Drug Description Nicardipine A calcium channel blocker used for the short-term treatment of hypertension and chronic stable angina. Delavirdine A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection. Gemfibrozil A lipid regulator that is used in the reduction of serum triglyceride levels in high-risk patients with hyperlipidemia. Capecitabine A nucleoside metabolic inhibitor indicated to treat colon, colorectal and breast cancer. Floxuridine An antimetabolite used as palliative management for liver metastases of gastrointestinal malignancy. Curcumin No approved therapeutic indications. Miconazole An azole antifungal with broad-spectrum activity used to treat fungal infections affecting the vagina, mouth and skin, including candidiasis. Sulfaphenazole For the treatment bacterial infections. Sorafenib A kinase inhibitor used in the treatment of unresectable liver carcinoma and advanced renal carcinoma. Clotrimazole A topical broad-spectrum antifungal agent used for the treatment of a wide variety of dermatophyte infections and candidiasis. Fluconazole A triazole antifungal used to treat various fungal infections including candidiasis. Tepotinib An oral tyrosine kinase inhibitor targeted against MET for the treatment of metastatic non-small cell lung cancer in patients exhibiting MET exon 14 skipping mutations.
- Drugs & Drug Targets